Preoperative Systemic Therapy Versus Upfront Surgery in HER2-Positive Breast Cancer in the Real World

PURPOSE: To compare survival in different strategies, preoperative systemic treatment versus upfront surgery, in HER2-positive early breast cancer patients in the real world. METHODS: According to the actual upfront treatment, eligible patients from 2012 to 2015 were classified as preoperative syste...

Descripción completa

Detalles Bibliográficos
Autores principales: Yu, Xingfei, Wang, Chen, Zheng, Yabing, Miao, Beibei, Hu, Jiejie, Shao, Xiying, Sheng, Liming, Lin, Juan, Ding, Yuqin, Xuan, Haojun, Ding, Yingying, Gong, Lijie, Feng, Weiliang, Qin, Chengdong, Chen, Daobao, Yu, Yang, Yang, Hongjian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356668/
https://www.ncbi.nlm.nih.gov/pubmed/34395277
http://dx.doi.org/10.3389/fonc.2021.704842

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356668/
https://www.ncbi.nlm.nih.gov/pubmed/34395277
http://dx.doi.org/10.3389/fonc.2021.704842

Ejemplares similares